Quang X. Pham, CEO and Chairman: Cadrenal Therapeutics CVKD Sell · Filed 06/02

Trade details

Type: Insider sale
Amount: $1,556.54
Shares · price: 349 sh · $4.46 a share
Held after: 181,509 sh
Stock: Cadrenal Therapeutics CVKD
Person: Quang X. PhamCEO and Chairman
Trade date: 26/06/02
Filed: 26/06/02
Days to filing: 0 days

Sold 0.2% of holdings

Share of holding sold: 0.2%

Cadrenal Therapeutics trades, last 26 weeks

What else happened in Cadrenal Therapeutics around then

Filed or reported within 30 days of the trade day · 05/03~07/02

Quang X. Pham's recent trades

Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$27.5K
9,029 sh
$27.5K
Filed 06/26
Traded 06/26
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$6,381
2,127 sh
$6,381
Filed 06/26
Traded 06/25
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$32.5K
9,167 sh
$32.5K
Filed 06/24
Traded 06/22
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$7,286
2,277 sh
$7,286
Filed 06/24
Traded 06/23
Quang X. PhamChairman, CEO and Interim CFO
Sell10b5-1 planCadrenal Therapeutics
Sell10b5-1 plan
Cadrenal Therapeutics
CVKD
$11.5K
3,613 sh
$11.5K
Filed 06/18
Traded 06/16

Quang X. Pham, Chairman — sold $1,557 of Cadrenal Therapeutics CVKD · 0.2% of holdings · 10b5-1 plan | Whalegun